PharmaShots | Incisive News in 3 Shots

Subscribe Now

NTRK Fusion-Positive

Roche's Rozlytrek Receives EC's Conditional Marketing Authorization for NTRK Fusion-Positive Solid Tumors and ROS1-Positive Advanced NSCLC

Roche's Rozlytrek Receives EC's Conditional Marketing Authorization for NTRK Fusion-Positive Solid Tumors and ROS1-Positive Advanc...

August 3, 2020

Roche's Rozlytrek (entrectinib) Receives MHLW's Approval for NTRK Fusion-Positive Advanced Recurrent Solid Tumors in Adult and Pediatric Patients in Japan

Roche's Rozlytrek (entrectinib) Receives MHLW's Approval for NTRK Fusion-Positive Advanced Recurrent Solid Tumors in Adult and Ped...

June 18, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us